Literature DB >> 2539161

Inhibition of dopamine beta-hydroxylase by captopril.

P Palatini1, F Dabbeni-Sala, P Finotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2539161     DOI： 10.1016/0006-2952(89)90293-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis.

Authors:  F R Ibarra; C Afione; D Garzon; M Barontini; J C Santos; E Arrizurieta
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Authors:  O V Volpert; W F Ward; M W Lingen; L Chesler; D B Solt; M D Johnson; A Molteni; P J Polverini; N P Bouck
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals.

Authors:  C Odaka; T Mizuochi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.